Laikai Pharmaceutical-B (02105) granted a total of 11.46 million restricted share units

Zhitongcaijing · 05/08 14:49

According to the Zhitong Finance App, Lai Kai Pharmaceutical-B (02105) issued an announcement to grant a total of 11.46 million restricted share units (equivalent to a total of 11.46 million shares) to the grantees (including 3 executive directors) in accordance with the 2024 share award plan. The granting of restricted share units to three executive directors, including Lu Xiangyang, Xie Ling, and Gu Xiangju, can only be realized after approval by independent shareholders at the annual shareholders' meeting.